Skip to main content
. 2019 Sep 18;14:313. doi: 10.1186/s13018-019-1322-7

Table 3.

Changes of CRP, VEGF and RI

Before the first stage After the first stage After the second stage
CRP (mg/L)
 Treatment regimen A 30.21 ± 6.98 27.33 ± 6.23a 29.96 ± 6.21
 Treatment regimen B 30.03 ± 8.33 29.55 ± 7.71 26.83 ± 6.08
VEGF (pg/ml)
 Treatment regimen A 180.22 ± 18.51 178.32 ± 16.10b 179.63 ± 17.59
 Treatment regimen B 182.87 ± 23.31 183.12 ± 21.40c 180.45 ± 20.49
RI (0~1)
 Treatment regimen A 0.53 ± 0.05 0.85 ± 0.04d 0.63 ± 0.04
 Treatment regimen B 0.54 ± 0.05 0.55 ± 0.06 0.83 ± 0.04

CRP C-reactive protein, VEGF vascular endothelial growth factor, RI resistance index

aCompared with that before the first stage (P = 0.032)

bCompared with that before the first stage (P = 0.230)

cCompared with that before the first stage (P = 0.120)

dCompared with that before the first stage (P < 0.001)